Covance Clinical Trials Business Impaired By Mergers, National Politics - CEO
Executive Summary
Covance's late-stage clinical trials business has been negatively impacted by the slew of industry mergers and the country's uncertain political climate, CEO Chris Kuebler remarked during the company's third quarter earnings conference call.